Table 2.
Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | Group 6 | Group 7 | Group 8 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | |
New fall | 0.99 (0.68–1.42) | 0.936 | 1.63 (0.76–3.48) | 0.210 | 0.98 (0.64–1.50) | 0.942 | 1.36 (1.07–1.72) | 0.012 | 1.25 (0.79–1.96) | 0.339 | 0.87 (0.33–2.30) | 0.785 | 1.47 (1.03–2.09) | 0.034 | (Base) |
New faint | 0.68 (0.29–1.61) | 0.380 | 1.58 (0.37–6.80) | 0.538 | 0.94 (0.37–2.38) | 0.902 | 0.85 (0.47–1.52) | 0.578 | 0.83 (0.29–2.35) | 0.722 | 0.89 (0.12–6.74) | 0.910 | 0.28 (0.07–1.14) | 0.076 | (Base) |
New ADL | 1.04 (0.74–1.47) | 0.822 | 1.58 (0.76–3.31) | 0.223 | 0.94 (0.62–1.43) | 0.775 | 0.92 (0.72–1.19) | 0.531 | 1.44 (0.95–2.21) | 0.089 | 1.08 (0.45–2.56) | 0.866 | 0.87 (0.59–1.28) | 0.480 | (Base) |
New IADL | 1.01 (0.71–1.42) | 0.975 | 1.54 (0.73–3.24) | 0.252 | 0.97 (0.64–1.47) | 0.890 | 0.84 (0.65–1.09) | 0.181 | 1.39 (0.91–2.12) | 0.129 | 0.87 (0.35–2.18) | 0.767 | 0.83 (0.56–1.22) | 0.336 | (Base) |
New cognitive decline | 1.25 (0.93–1.67) | 0.134 | 1.25 (0.63–2.50) | 0.524 | 0.79 (0.54–1.14) | 0.210 | 0.98 (0.79–1.22) | 0.876 | 1.63 (1.12–2.36) | 0.011 | 0.99 (0.46–2.16) | 0.988 | 0.82 (0.58–1.15) | 0.240 | (Base) |
Mortality | 1.17 (0.60–2.29) | 0.653 | 0.49 (0.06–3.80) | 0.495 | 0.98 (0.48–2.76) | 0.970 | 0.95 (0.53–1.69) | 0.856 | 1.64 (0.77–3.49) | 0.203 | 0.47 (0.06–3.81) | 0.477 | 0.63 (0.22–1.76) | 0.377 | (Base) |
Abbreviations: OR: odds ratio; CI: confidence interval; ADL: activities of daily living; IADL: instrumental activities of daily living.